Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI).
Am Heart J
; 200: 110-117, 2018 06.
Article
in En
| MEDLINE
| ID: mdl-29898838
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Insulin-Like Growth Factor I
/
Ventricular Dysfunction, Left
/
Percutaneous Coronary Intervention
/
ST Elevation Myocardial Infarction
/
Heart Ventricles
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Am Heart J
Year:
2018
Type:
Article